Andrew McKenzie

Andrew McKenzie serves as the Clinical Development Director at Percheron Therapeutics Limited since June 2023, bringing extensive experience from a 24-year tenure at CSL, where roles included Associate Director, Clinical Scientist, Global Principal Clinical Scientist, Senior Clinical Safety Scientist, Clinical Safety Scientist, Senior Clinical Research Associate, Clinical Research Associate, Clinical Trials Assistant, and Research Scientist. Andrew holds a Doctor of Philosophy (PhD) in Medical Biology from the Walter and Eliza Hall Institute, Melbourne (1996-1999), and a Bachelor of Science (BSc) with Honors in Immunology from the University of Melbourne (1992-1995).